Tech Company Financing Transactions

Flexion Therapeutics Funding Round

On 12/4/2012, Flexion Therapeutics secured $20 million in Series B financing from Novo Ventures, 5AM Ventures and Pfizer Venture Investments.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B

Novo Ventures (Lead Investor) (Heath Lukatch)

5AM Ventures (Andrew Schwab)

Pfizer Venture Investments (Elaine Jones)

Sofinnova Ventures (Rafaele Tordjman)

Versant Ventures (Brad Bolzon)

Proceeds Purpose
Proceeds will be used to fund late stage clinical development of the company's portfolio of intra-articular, sustained release therapies for the treatment of osteoarthritis.

Company Information

Company Status
Mailing Address
10 Mall Rd. 301
Burlington, MA 01803
Email Address
Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies.
Flexion Therapeutics LinkedIn Company Profile
Social Media
Flexion Therapeutics Company Twitter Account
Company News
Flexion Therapeutics News
Flexion Therapeutics on Facebook
Flexion Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Clayman
  Michael Clayman LinkedIn Profile  Michael Clayman Twitter Account  Michael Clayman News  Michael Clayman on Facebook
Chief Medical Officer
Scott Kelley
  Scott Kelley LinkedIn Profile  Scott Kelley Twitter Account  Scott Kelley News  Scott Kelley on Facebook
Vice President
Christina Willwerth
  Christina Willwerth LinkedIn Profile  Christina Willwerth Twitter Account  Christina Willwerth News  Christina Willwerth on Facebook
VP - Bus. Development
Adam Muzikant
  Adam Muzikant LinkedIn Profile  Adam Muzikant Twitter Account  Adam Muzikant News  Adam Muzikant on Facebook
VP - General Counsel
Mark Levine
  Mark Levine LinkedIn Profile  Mark Levine Twitter Account  Mark Levine News  Mark Levine on Facebook
VP - Operations
Daniel Leblanc
  Daniel Leblanc LinkedIn Profile  Daniel Leblanc Twitter Account  Daniel Leblanc News  Daniel Leblanc on Facebook
VP - Regulatory Affairs
Kerry Wentworth
  Kerry Wentworth LinkedIn Profile  Kerry Wentworth Twitter Account  Kerry Wentworth News  Kerry Wentworth on Facebook



Browse more venture capital transactions:

Prev: 12/3/2012: SmartSheet venture capital transaction
Next: 12/4/2012: HydroNovation venture capital transaction


Share this article


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary